The California Institute for Regenerative Medicine Science, Governance, and the Pursuit of Cures (2013) / Chapter Skim
Currently Skimming:
Appendix B: Summary of Questionnaires
Appendix B: Summary of Questionnaires
Pages 145-158
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 145... ...
from members of the Independent Citizens Oversight Committee (ICOC) , the leadership of California Institute for Regenerative Medicine (CIRM)
|
From page 146... ...
The remainder of this appendix provides brief summaries and highlights of the thoughts, perspectives, and concerns articulated by various respondents on CIRM's organizational processes, its programmatic and scientific scope, its organizational and management systems, its funding model, and its intellectual property policies. RESPONSES TO QUESTIONNAIRE FOR MEMBERS OF THE INDEPENDENT CITIZENS OVERSIGHT COMMITTEE There is little question that members of the ICOC are proud of CIRM's overall record of accomplishment in establishing California as one of the key worldwide hubs of research in regenerative medicine.
|
From page 147... ...
There have clearly been big "winners" in this competition, and those institutions are the ones for which CIRM funding has had the largest positive impact, including recruiting faculty from outside California and building entirely new buildings for stem cell research funded by a combination of CIRM facilities awards and private gifts. RESPONSES TO QUESTIONNAIRE FOR PRINCIPAL INVESTIGATORS FUNDED BY CIRM Most principal investigators who responded to the questionnaire felt that CIRM's priorities were clearly articulated, that the requests for applications (RFAs)
|
From page 148... ...
Respondents made several suggestions for improving CIRM's intellectual property policies. They include reducing burdens on grant recipients and potential licensees; clarifying regulations and policy definitions; clarifying guidelines for implementation and for compliance; holding quarterly videoconferencing; networking to identify possible licensees; and modifying licensing sections, especially in drug pricing and royalty sharing with the state.
|
From page 149... ...
However, the committee recognizes the difficulty of assessing this input given the small number of responses and with little knowledge of the backgrounds of the respondents themselves. Most respondents to the public questionnaire felt that CIRM took a leadership role in establishing infrastructures for biomedical research, providing funding for a research area that lacked federal financial support, attracting and retaining distinguished stem cell scientists, creating important partnerships with many countries, promoting collaboration among researchers around the world, and stimulating similar programs in other states.
|
From page 150... ...
The IOM Committee on a Review of the California Institute for Regenerative Medicine will as sess the organization's initial processes, its programmatic and scientific scope, organizational and management systems, funding model, and intellectual property policies. To help the committee address its charge, it would like to obtain input from members of the Independent Citizens Oversight Committee (ICOC)
|
From page 151... ...
Question 14: How effectively does the ICOC work with CIRM Board Chair and President? Are roles and responsibilities clearly defined?
|
From page 152... ...
to provide an independent assessment of CIRM's programs, operations, and performance. The IOM Committee on a Review of the California Institute for Regenerative Medicine will as sess the organization's initial processes, its programmatic and scientific scope, organizational and management systems, funding model, and intellectual property policies.
|
From page 153... ...
to provide an independent assessment of CIRM's programs, operations, and performance. The IOM Committee on a Review of the California Institute for Regenerative Medicine will as sess the organization's initial processes, its programmatic and scientific scope, organizational and management systems, funding model, and intellectual property policies.
|
From page 154... ...
to provide an independent assessment of CIRM's programs, operations, and performance. The IOM Committee on a Review of the California Institute for Regenerative Medicine will as sess the organization's initial processes, its programmatic and scientific scope, organizational and management systems, funding model, and intellectual property policies.
|
From page 155... ...
The IOM Committee on a Review of the California Institute for Re generative Medicine will assess the organization's initial processes, its programmatic and scientific scope, organizational and management systems, funding model, and intellectual property policies. To help the committee address its charge, members of the public are invited to share their thoughts, perspectives and/or concerns about CIRM.
|
From page 156... ...
to provide an independent assessment of CIRM's programs, operations, and performance. The IOM Committee on a Review of the California Institute for Regenerative Medicine will as sess the organization's initial processes, its programmatic and scientific scope, organizational and management systems, funding model, and intellectual property policies.
|
From page 157... ...
to provide an independent assessment of CIRM's programs, operations, and performance. The IOM Committee on a Review of the California Institute for Regenerative Medicine will as sess the organization's initial processes, its programmatic and scientific scope, organizational and management systems, funding model, and intellectual property policies.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.